ANGO Angiodynamic Inc
779
$5.81
$0.23
(3.81%)
| Watchers | 779 |
| 52-Wk Low | $5.26 |
| 52-Wk High | $11.38 |
| Market Cap | $232.72M |
| Volume | 349,113.00 |
| 52-Wk High | $11.38 |
| 52-Wk Low | $5.26 |
AngioDynamics APEX-AV Trial Results Assessing AlphaVac F18 System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsBusiness Wire • 14 days ago
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...
Share to Feed
AngioDynamics (NASDAQ:ANGO - Get Free Report) was upgraded by stock analysts at Oppenheimer from a "market perform" rating to an "outperform" rating in a report released on Friday, Marketbeat Ratings...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
ANGO reports solid revenue growth with strategic advancements, despite facing margin pressures and a significant GAAP net loss.Related Stocks: ANGO...
Related Stocks: NAS:ANGO...
ANGO's Earnings Miss Analyst Projections Despite Revenue GrowthRelated Stocks: ANGO...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
AngioDynamics Non-GAAP EPS of -$0.16, revenue of $65.97M...
AngioDynamics, Inc. (NASDAQ: ANGO): Fiscal Year 2024 Third Quarter Highlights Completed the sale of its PICC and Midline product portfolios to Spectrum Vascular on February 15, 2024 Discontinued its...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...